NEW FORMULATIONS OF FOSFOMYCIN WITH REDUCED SODIUM CONTENT FOR PARENTERAL USE AND METHODS OF PRODUCING THE SAME

摘要

The present invention relates to crystalline fosfomycin salts comprising 0.8 to 1.2 equivalents sodium relative to one equivalent fosfomycin, as well as a pharmaceutical composition and injectable preparation comprising the same. The present invention further refers to a method for producing said crystalline fosfomycin salts, pharmaceutical compositions and injectable preparations, and to the use thereof in therapy and in treating a specific patient group.